CLEOCIN VAGINAL CREAM Rx
Generic Name and Formulations:
Clindamycin (as phosphate) 2%.
Indications for CLEOCIN VAGINAL CREAM:
1 applicatorful intravaginally at bedtime. Nonpregnant: treat for 3 or 7 days. Pregnant (2nd or 3rd trimester): treat for 7 days.
History of enteritis or colitis.
Monitor for pseudomembranous colitis. Do not use contraceptive diaphragm or condom for at least 72hrs after treatment. Do not have vaginal intercourse or use tampons or douches during treatment with ovules. Pregnancy. Nursing mothers: monitor infant or consider alternatives.
May potentiate neuromuscular blockers; caution.
Candidiasis, vaginitis, vulvovaginal disorder, fungal infection, pruritus, abnormal labor.
Crm—40g (w. applicators); Ovules—3 (w. applicator)
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Prevalence of ADHD Relatively Stable Over Time Despite Increase in Diagnoses
- Genetic Variations Associated With Empathy Affect Psychiatric Conditions
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders
- Mortality Rates for Substance Use Disorders, Intentional Injuries Vary Widely By Country
- Facial Emotion Recognition Differentiates Behavioral Variant Frontotemporal Dementia From MDD
- The Challenge of Helping Uninsured Patients While Protecting Practice Finances
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed